Energy News / Shareholders Foundation, Inc.

NASDAQ:OSIR Investor Alert: Investigation of Takeover of Osiris Therapeutics, Inc.

Via: ReleaseWire

Updated 11:15 AM CDT, Mon, March 18,2019

An investigation on behalf of investors of Osiris Therapeutics, Inc. (NASDAQ: OSIR) in connection with the proposed takeover was announced and NASDAQ: OSIR stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 03/18/2019 -- An investigation was announced concerning the takeover of Osiris Therapeutics, Inc.

Investors who purchased shares of Osiris Therapeutics, Inc. (NASDAQ: OSIR) and currently hold any of those NASDAQ: OSIR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain officers and directors of Osiris Therapeutics, Inc. breached their fiduciary duties owed to NASDAQ: OSIR investors in connection with the proposed acquisition.

On March 12, 2019, Osiris Therapeutics, Inc. (NASDAQ: OSIR) announced that it has entered into an agreement and plan of merger with Smith & Nephew plc pursuant to which Smith & Nephew will acquire Osiris for $19.00 per share in cash, a total of approximately $660.5 million in cash.

However, the investigation concerns whether the offer is unfair to NASDAQ: OSIR stockholders. More specifically, the investigation concerns whether the Osiris Therapeutics Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

On March 15, 2019, NASDAQ: OSIR shares closed at $19.06 per share.

Those who are current investors in Osiris Therapeutics, Inc. (NASDAQ: OSIR) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqosir-investor-alert-investigation-of-takeover-of-osiris-therapeutics-inc-1173918.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com